Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Apr;141(4S Sientra Shaped and Round Cohesive Gel Implants):7S-19S.
doi: 10.1097/PRS.0000000000004350.

Ten-year Core Study Data for Sientra's Food and Drug Administration-Approved Round and Shaped Breast Implants with Cohesive Silicone Gel

W Grant Stevens  1   2 , M Bradley Calobrace  1   2 , Kaveh Alizadeh  1   2 , Kamakshi R Zeidler  1   2 , Jennifer L Harrington  1   2 , Rosalyn C d'Incelli  1   2
Affiliations
Clinical Trial

Ten-year Core Study Data for Sientra's Food and Drug Administration-Approved Round and Shaped Breast Implants with Cohesive Silicone Gel

W Grant Stevens et al. Plast Reconstr Surg. 2018 Apr.

Abstract

Background: In March 2012, the United States Food and Drug Administration approved Sientra's application for premarket approval of its portfolio of round and shaped silicone gel breast implants based on data from the largest silicone gel breast implant study to date. This article presents the results of Sientra's Core Study at the conclusion of 10 years.

Methods: The Sientra Core Study was a 10-year, open-label, prospective, multicenter clinical study designed to assess the safety and effectiveness of Sientra's breast implants in augmentation and reconstruction. A total of 1,788 patients (3,506 implants) were enrolled, including 1,116 primary augmentation, 363 revision-augmentation, 225 primary reconstruction, and 84 revision-reconstruction.

Results: Across all cohorts, the rate of rupture by patient was 8.6%, the rate of Baker grade III/IV capsular contracture was 13.5%, and the rate of reoperation was 31.5%. The rate of capsular contracture was statistically significantly lower for textured devices [9.0%; 95% confidence interval (CI), 7.0-11.5%] compared with smooth devices (17.5%; 95% CI, 14.9-20.4%). There were no cases of breast implant-associated anaplastic large cell lymphoma. Primary reasons for reoperations included capsular contracture (18.8%), and style/size change (19.3%), with over 50% of the reoperations due to cosmetic reasons.

Conclusion: The 10-year results of Sientra's Core Study support a comprehensive safety and effectiveness profile of Sientra's portfolio of round and shaped breast implants.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cronin TD, Gerow FJ. Augmentation mammoplasty: a new “natural feel” prosthesis. Transactions of the Third International Congress of Plastic Surgery. Washington, DC, October 13–18, 1963. 1964.Amsterdam, The Netherlands: Excerpta Medica.
    1. Berry MG, Davies DM. Breast augmentation: Part I—A review of the silicone prosthesis. J Plast Reconstr Aesthet Surg. 2010;63:17611768.
    1. Calobrace MB, Capizzi PJ. The biology and evolution of cohesive gel and shaped implants. Plast Reconstr Surg. 2014;134:6S11S.
    1. Maxwell GP, Gabriel A. The evolution of breast implants. Plast Reconstr Surg. 2014;134:12S17S.
    1. Spear S. The breast implant story. Ann Plast Surg. 2006;56:573583.

MeSH terms